Indonesia approved China’s Sinovac Biotech Ltd. shots for emergency use, paving the way for Southeast Asia’s largest economy to start its inoculation program.
The Sinovac vaccine was found to be about 65% effective against Covid-19 in late stage-trials in the city of Bandung, Penny Lukito, head of the food and drug regulator, said in a press briefing Monday. The regulator also considered data from clinical trials in Brazil and Turkey in making the decision, she said.
The vaccine is “largely safe,” Lukito said. “It brings hope of reducing the Covid cases.”
The emergency use authorization is the first for Sinovac’s vaccine outside of China. In Brazil, late stage-trials showed an efficacy rate of 78%. The vaccine was effective in preventing mild cases of the virus and 100% effective against severe and moderate infections, according to the Brazil government.